Supply Chain

Both during and after vaccine distribution, the pharma cold chain will be vastly expanded

Pharma is now one of Nippon Express’ ‘priority industries’ for global logistics services

National Academy of Medicine offers a vaccine allocation ‘framework’; will it be followed?

Data is beginning to trickle out on storage and shipping conditions for the new vaccines

Deal is boosted by a $275-million investment from Blackstone Group

Proteus Digital Health, a pioneer, crashes and burns, while EtectRx appoints a new CEO

$58-million acquisition nearly doubles Cryoport’s size

DoseID consortium brings pharma RFID users together while employing GS1 standards

Keeping clinical trials on track has been no easy task; enter patient concierge services

CDC invokes an existing contract option to choose the US’ largest drug distributor

The emergence of natural language processing in pharmacovigilance

There are now 11 cell/gene therapies targeting Covid-19 in development

UPS is building capacity for -80°C storage; DHL expands in Indianapolis

127,000-sq. ft. facility opens in Libertyville, IL

The PharmaPortal platform is built on IBM’s Blockchain Transparent Supply technology

Morris & Dickson’s president proposes a way forward

Pelican Biothermal’s 2020 study highlights gap between corporate goals and distribution practices

Steady progress is occurring in the global effort to track pharmaceutical distribution, even as new technical and business opportunities appear

More warehouse capacity, plus a growing investment in robotics

Passive containers maintain a -20°C temperature spec

TransCelerate opens up its network to qualified researchers; Oracle has a new platform

SensiWatch Platform includes analytics and APIs for integrating supply-chain information

Also: more innovative cold-chain actions during the Covid-19 pandemic

1.3-million sq. ft to be added in the US and Europe

Guidance for companies starting out on the commercialization path

Guidance for companies starting out on the commercialization path

Chain of identity, chain of custody are high priorities for autologous therapies

Service can be multimodal and multi-provider, and is not device-dependent